Research Topics
Subscribe to Research Topics

The Lead

Diabetes Drug Spurs Weight Loss, But Not Without Side Effects

July 2, 2015 12:30 pm | by Stephanie Guzowski, Editor | News | Comments

The injectable drug liraglutide, marketed as Saxenda, can help overweight or obese patients lose a significant amount of weight — but a study in the New England Journal of Medicine reports that the drug also carries several side effects. Read more...

Researcher Who Faked HIV Vaccine Gets Prison Term, Millions in Fines

July 2, 2015 10:56 am | by Seth Augenstein, Digital Reporter | News | Comments

A scientist who faked results of an experimental HIV vaccine in rabbits to make it appear he had...

The Drunkest Eye: Do Those Baby Blues Mean Higher Rates of Problem Drinking?

July 2, 2015 10:25 am | by Seth Augenstein, Digital Reporter | News | Comments

Blue eyes could be a risk factor for alcohol dependence, according to a new Univ. of Vermont ...

Researchers Invent Device That Makes Chemotherapy More Personalized, Efficient

July 2, 2015 10:17 am | by University of Florida | News | Comments

Two University of Florida researchers have invented a device that makes chemotherapy treatments...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Statins Linked to Lower Aggression in Men, But Higher in Women

July 2, 2015 10:11 am | by University of California - San Diego | News | Comments

Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. Read more...

One in Four People Prescribed Opioids Progressed to Longer-Term Prescriptions

July 2, 2015 9:56 am | by Mayo Clinic | News | Comments

Opioid painkiller addiction and accidental overdoses have become far too common across the United States. To try to identify who is most at risk, Mayo Clinic researchers studied how many patients prescribed an opioid painkiller for the first time progressed to long-term prescriptions. Read more...

Trends in Antipsychotic Medication Use in Children, Adolescents, and Young Adults

July 2, 2015 9:22 am | by Columbia University | News | Comments

Despite concerns that use of antipsychotic medications in treating young people has increased, use actually declined between 2006 and 2010 for children ages 12 and under, and increased for adolescents and young adults. Read more..


Small, Magnetic Robots Aim to Inject Drugs into the Bloodstream

July 1, 2015 4:38 pm | by Ryan Bushey, Associate Editor | Videos | Comments

The team has been working on a system of “milirobots” that are capable of swimming through a person’s bloodstream or spinal fluid. Read more...

Study Offers Clue to Link Between Swine Flu Shot, Narcolepsy

July 1, 2015 4:21 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

One vaccine used in Europe during the 2009 swine flu pandemic was linked to rare cases of a baffling side effect - the sleep disorder narcolepsy. Now new research offers a clue to what happened. Read more...

Bowel Cancer Risk Reduced by Taking Aspirin for Lynch Syndrome Patients

July 1, 2015 4:09 pm | by University of Melbourne | News | Comments

This is the largest study to date investigating the associations between aspirin, ibuprofen and bowel cancer risk for people with Lynch syndrome. Read more...

Cancer Surgery or Biospy Collection Could Influence Disease Progression

July 1, 2015 3:53 pm | by University of Bristol | News | Comments

Scientists studying the body’s inflammatory response to wounds following cancer surgery or biopsy have found that these procedures may cause growth signals to be delivered to any remaining cancer or pre-cancerous cells which may negatively influence disease progression. Read more...

Stem Cell Gene Therapy Holds Promise for Eliminating HIV Infection

July 1, 2015 10:32 am | by UCLA | News | Comments

Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are one step closer to engineering a tool that could one day arm the body’s immune system to fight HIV — and win. The new technique harnesses the regenerative capacity of stem cells to generate an immune response to the virus. Read more...


Outsmarting HIV With Vaccine Antigens Made to Order

July 1, 2015 10:24 am | by Robin Smith, Duke University | News | Comments

AIDS vaccine researchers may be one step closer to outwitting HIV, thanks to designer antibodies and antigens made to order at Duke. Read more...

Avian Flu: $1.35M Grant Funds Bid to Better Predict Deadly Outbreaks

July 1, 2015 10:10 am | by University of Virginia Health System | News | Comments

An international research team led by Lukas Tamm of the University of Virginia School of Medicine will receive $1.35 million from the Human Frontier Science Program Organization to better understand how the influenza virus passes from birds to humans. Read more...

Oxycontin Maker Bows Out of Meeting on Harder-to-Abuse Drug

July 1, 2015 10:02 am | by Matthew Perrone, AP Health Writer - Associated Press | News | Comments

The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug. Read more...

Forgetfulness and Errors Can Signal Alzheimer’s Decades Before Diagnosis

July 1, 2015 9:32 am | by Seth Augenstein, Digital Reporter | News | Comments

Mistakes on memory and thought tests may give an indication of the future onset of Alzheimer’s, up to 18 years before diagnosis, according to a new study. Read more...

How Removing a Protein Slows Blood Vessel Growth in Tumors

July 1, 2015 8:43 am | by University of Leeds | News | Comments

Scientists have discovered a new protein which triggers the growth of blood vessels in breast cancer tumors which have spread to the brain. Read more...


Oramed Enrolls First Patient in its Phase 2B Oral Insulin Study

July 1, 2015 8:36 am | News | Comments

This U.S. based study will be performed under the active Investigational New Drug application on file with the U.S. Food and Drug Administration. Read more...

Research Reveals New Insights into Key Antibiotic Target in Fight Against TB

July 1, 2015 8:30 am | by University of Sussex | News | Comments

While TB is curable, antibiotic resistance is on the rise and so a major challenge for scientists is to continually develop new drugs to treat the disease. Read more...

BiondVax Announces Positive Preliminary Phase 2 Results for Universal Flu Vaccine

July 1, 2015 8:29 am | News | Comments

These results support BiondVax’s claim that M-001 provides a broaden and improved coverage against multiple influenza type A and B virus strains. Read more...

Novartis to Try Novel Pricing Strategy for Heart Failure Drug

July 1, 2015 8:27 am | by Ryan Bushey, Associate Editor | Articles | Comments

The company is treading carefully in establishing the exact cost per pill. Read more...

The Leukemia & Lymphoma Society Accelerates Payment Linked to Phase 3 AML Study

June 30, 2015 12:24 pm | by The Leukemia & Lymphoma Society | News | Comments

Celator Pharmaceuticals, Inc. today announced that The Leukemia & Lymphoma Society (LLS) is accelerating a portion of the final payment linked to the Phase 3 study of CPX-351 (cytarabine:daunorubicin) liposome injection, Celator's lead product candidate, for the treatment of patients with high-risk (secondary) acute myeloid leukemia (AML). Read more...

National Study Finds Life-Threatening Barriers in Access to Breakthrough Drugs

June 30, 2015 12:16 pm | by Lifespan | News | Comments

Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C, according to Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection Program.  Read more...

Treatment With PI3K Inhibitors May Cause Cancers to Become Aggressive, Metastatic

June 30, 2015 11:43 am | by The Wistar Institute | News | Comments

The enzyme phosphatidylinositol-3 kinase (PI3K) appears to be exploited in almost every type of human cancer, making it the focus of considerable interest as a therapeutic target, with many PI3K-inhibiting drugs currently in various stages of clinical development.  Read more...

Merck: Phase 3 Study of Single-Dose Emend Met Primary Endpoint

June 30, 2015 11:36 am | News | Comments

Merck, known as MSD outside the United States and Canada, today announced results from a Phase 3 study investigating the safety and efficacy of single-dose EMEND (fosaprepitant dimeglumine) for Injection, Merck’s substance P/neurokinin (NK-1) receptor antagonist, in combination with other anti-vomiting medicines, for the prevention of chemotherapy-induced nausea and vomiting (CINV). Read more...

New Study Verifies Accuracy of Rapid Ebola Test

June 30, 2015 8:18 am | by Tulane University | News | Comments

The study results confirm that the test can be used in the field and deliver a high level of accuracy. Read more...

Multi-Million-Dollar Deal Brings UQ Pain Drug Closer to Reality

June 30, 2015 8:18 am | by University of Queensland | News | Comments

A chronic pain treatment discovered at The University of Queensland is a step closer to clinical use. Read more...

Lilly, Immunocore: Immunotherapy-based Clinical Trial Collaboration in Melanoma

June 29, 2015 9:48 am | News | Comments

Eli Lilly and Company and Immunocore Limited today announced that they have entered into an immunotherapy-based clinical trial collaboration to explore the utility of Immunocore's lead T cell receptor-based investigational therapeutic, IMCgp100, in combination with Lilly's galunisertib (LY2157299) and merestinib (LY2801653) for the treatment of melanoma. Read more...

Scientists Look Into Why Most Alzheimer's Patients Are Women

June 29, 2015 9:42 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Nearly two-thirds of Americans with Alzheimer's disease are women, and now some scientists are questioning the long-held assumption that it's just because they tend to live longer than men. Read more..

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.